Study suggests Pfizer’s COVID-19 vaccine less effective against South African variant
- Britain and many other countries have begun rolling out the Pfizer-BioNTech vaccine to try to stem the spread of the pandemic disease
- When the scientists added all the key mutations found in the B1.1.7 and E484K variants, they found the efficacy of the vaccine was affected